An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression

Ying Wang, Xianting Li, Lu Wang, Peiguo Ding, Yingmei Zhang, Wenling Han, Dalong Ma

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

Accumulating reports demonstrate that apoptosis does not explain all the forms of programmed cell death (PCD), particularly in individual development and neurodegenerative disease. Recently, a novel type of PCD, designated 'paraptosis', was described. Here, we show that overexpression of TAJ/TROY, a member of the tumor necrosis factor receptor superfamily, induces non-apoptotic cell death with paraptosis-like morphology in 293T cells. Transmission electron microscopy studies reveal extensive cytoplasmic vacuolation and mitochondrial swelling in some dying cells and no condensation or fragmentation of the nuclei. Characteristically, cell death triggered by TAJ/TROY was accompanied by phosphatidylserine externalization, loss of the mitochondrial transmembrane potential and independent of caspase activation. In addition, TAJ/TROY suppressed clonogenic growth of HEK293 and HeLa cells. Interestingly, overexpression of Programmed cell death 5 (PDCD5), an apoptosis-promoting protein, enhanced TAJ/TROY-induced paraptotic cell death. Moreover, cellular endogenous PDCD5 protein was significantly upregulated in response to TAJ/TROY overexpression. These results provide novel evidence that TAJ/TROY activates a death pathway distinct from apoptosis and that PDCD5 is an important regulator in both apoptotic and non-apoptotic PCD.

Original languageEnglish (US)
Pages (from-to)1525-1532
Number of pages8
JournalJournal of Cell Science
Volume117
Issue number8
DOIs
StatePublished - Mar 15 2004

Fingerprint

Cell Death
HEK293 Cells
Apoptosis
Mitochondrial Swelling
Apoptosis Regulatory Proteins
Tumor Necrosis Factor Receptors
Phosphatidylserines
Caspases
Transmission Electron Microscopy
HeLa Cells
Neurodegenerative Diseases
Membrane Potentials
Growth
Proteins

Keywords

  • Non-apoptotic
  • Paraptosis
  • PDCD5
  • TAJ/TROY
  • TFAR19

ASJC Scopus subject areas

  • Cell Biology

Cite this

An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. / Wang, Ying; Li, Xianting; Wang, Lu; Ding, Peiguo; Zhang, Yingmei; Han, Wenling; Ma, Dalong.

In: Journal of Cell Science, Vol. 117, No. 8, 15.03.2004, p. 1525-1532.

Research output: Contribution to journalArticle

Wang, Ying ; Li, Xianting ; Wang, Lu ; Ding, Peiguo ; Zhang, Yingmei ; Han, Wenling ; Ma, Dalong. / An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. In: Journal of Cell Science. 2004 ; Vol. 117, No. 8. pp. 1525-1532.
@article{69266a4b9bb7448ba2e3a1d9c3005f30,
title = "An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression",
abstract = "Accumulating reports demonstrate that apoptosis does not explain all the forms of programmed cell death (PCD), particularly in individual development and neurodegenerative disease. Recently, a novel type of PCD, designated 'paraptosis', was described. Here, we show that overexpression of TAJ/TROY, a member of the tumor necrosis factor receptor superfamily, induces non-apoptotic cell death with paraptosis-like morphology in 293T cells. Transmission electron microscopy studies reveal extensive cytoplasmic vacuolation and mitochondrial swelling in some dying cells and no condensation or fragmentation of the nuclei. Characteristically, cell death triggered by TAJ/TROY was accompanied by phosphatidylserine externalization, loss of the mitochondrial transmembrane potential and independent of caspase activation. In addition, TAJ/TROY suppressed clonogenic growth of HEK293 and HeLa cells. Interestingly, overexpression of Programmed cell death 5 (PDCD5), an apoptosis-promoting protein, enhanced TAJ/TROY-induced paraptotic cell death. Moreover, cellular endogenous PDCD5 protein was significantly upregulated in response to TAJ/TROY overexpression. These results provide novel evidence that TAJ/TROY activates a death pathway distinct from apoptosis and that PDCD5 is an important regulator in both apoptotic and non-apoptotic PCD.",
keywords = "Non-apoptotic, Paraptosis, PDCD5, TAJ/TROY, TFAR19",
author = "Ying Wang and Xianting Li and Lu Wang and Peiguo Ding and Yingmei Zhang and Wenling Han and Dalong Ma",
year = "2004",
month = "3",
day = "15",
doi = "10.1242/jcs.00994",
language = "English (US)",
volume = "117",
pages = "1525--1532",
journal = "Journal of Cell Science",
issn = "0021-9533",
publisher = "Company of Biologists Ltd",
number = "8",

}

TY - JOUR

T1 - An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression

AU - Wang, Ying

AU - Li, Xianting

AU - Wang, Lu

AU - Ding, Peiguo

AU - Zhang, Yingmei

AU - Han, Wenling

AU - Ma, Dalong

PY - 2004/3/15

Y1 - 2004/3/15

N2 - Accumulating reports demonstrate that apoptosis does not explain all the forms of programmed cell death (PCD), particularly in individual development and neurodegenerative disease. Recently, a novel type of PCD, designated 'paraptosis', was described. Here, we show that overexpression of TAJ/TROY, a member of the tumor necrosis factor receptor superfamily, induces non-apoptotic cell death with paraptosis-like morphology in 293T cells. Transmission electron microscopy studies reveal extensive cytoplasmic vacuolation and mitochondrial swelling in some dying cells and no condensation or fragmentation of the nuclei. Characteristically, cell death triggered by TAJ/TROY was accompanied by phosphatidylserine externalization, loss of the mitochondrial transmembrane potential and independent of caspase activation. In addition, TAJ/TROY suppressed clonogenic growth of HEK293 and HeLa cells. Interestingly, overexpression of Programmed cell death 5 (PDCD5), an apoptosis-promoting protein, enhanced TAJ/TROY-induced paraptotic cell death. Moreover, cellular endogenous PDCD5 protein was significantly upregulated in response to TAJ/TROY overexpression. These results provide novel evidence that TAJ/TROY activates a death pathway distinct from apoptosis and that PDCD5 is an important regulator in both apoptotic and non-apoptotic PCD.

AB - Accumulating reports demonstrate that apoptosis does not explain all the forms of programmed cell death (PCD), particularly in individual development and neurodegenerative disease. Recently, a novel type of PCD, designated 'paraptosis', was described. Here, we show that overexpression of TAJ/TROY, a member of the tumor necrosis factor receptor superfamily, induces non-apoptotic cell death with paraptosis-like morphology in 293T cells. Transmission electron microscopy studies reveal extensive cytoplasmic vacuolation and mitochondrial swelling in some dying cells and no condensation or fragmentation of the nuclei. Characteristically, cell death triggered by TAJ/TROY was accompanied by phosphatidylserine externalization, loss of the mitochondrial transmembrane potential and independent of caspase activation. In addition, TAJ/TROY suppressed clonogenic growth of HEK293 and HeLa cells. Interestingly, overexpression of Programmed cell death 5 (PDCD5), an apoptosis-promoting protein, enhanced TAJ/TROY-induced paraptotic cell death. Moreover, cellular endogenous PDCD5 protein was significantly upregulated in response to TAJ/TROY overexpression. These results provide novel evidence that TAJ/TROY activates a death pathway distinct from apoptosis and that PDCD5 is an important regulator in both apoptotic and non-apoptotic PCD.

KW - Non-apoptotic

KW - Paraptosis

KW - PDCD5

KW - TAJ/TROY

KW - TFAR19

UR - http://www.scopus.com/inward/record.url?scp=2142848181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142848181&partnerID=8YFLogxK

U2 - 10.1242/jcs.00994

DO - 10.1242/jcs.00994

M3 - Article

C2 - 15020679

AN - SCOPUS:2142848181

VL - 117

SP - 1525

EP - 1532

JO - Journal of Cell Science

JF - Journal of Cell Science

SN - 0021-9533

IS - 8

ER -